Rachel Feltman: For Scientific American’s Science Rapidly, I’m Rachel Feltman.
For greater than a decade noninvasive prenatal blood testing, or NIPT, has grow to be a reasonably routine facet of being pregnant care. This testing searches a pregnant individual’s blood for fragments of DNA which have been shed by the placenta. NIPT is designed to identify chromosomal issues within the fetus, however in uncommon instances the blood exams can detect one thing else: most cancers within the mother or father.
My visitor at present is Laura Herscher, a genetic counselor and director of scholar analysis on the Sarah Lawrence Faculty Joan H. Marks Graduate Program in Human Genetics. She just lately wrote a chunk for Scientific American in regards to the researchers working to grasp how NIPT finds most cancers in some pregnant individuals. She’s right here to inform us extra in regards to the Incidental Detection of Maternal Neoplasia by way of Non-invasive Cell-Free DNA Evaluation research, or IDENTIFY for brief.
On supporting science journalism
In case you’re having fun with this text, take into account supporting our award-winning journalism by subscribing. By buying a subscription you’re serving to to make sure the way forward for impactful tales in regards to the discoveries and concepts shaping our world at present.
Laura, thanks a lot for approaching to talk at present.
So you lately wrote about one thing referred to as the IDENTIFY research. How did you get on this story?
Laura Hercher: Effectively, the primary time I heard about IDENTIFY was when the principal investigator, Diana Bianchi from, from [the Eunice Kennedy Shriver National Institute of Child Health and Human Development], talked about her preliminary outcomes, which was nearly a yr in the past—it was, like, March of 2024. And he or she mentioned that she was taking a look at one thing I had heard about, that had crossed my, you understand, radar, however I actually wasn’t paying that a lot consideration, which was these bizarre and funky prenatal testing outcomes, which, as an alternative of giving again data on the fetus, unexpectedly supplied data on the pregnant particular person themselves. And I’d heard, considerably nearly by rumor, from prenatal genetic counselors that generally these oddball genetic testing outcomes truly appear to see a sign for most cancers within the mother.
Feltman: Mm.
Hercher: However, you understand, most most cancers screens, even once they’re set as much as be most cancers screens, the return on them is normally restricted. Nevertheless, on this case, she reported that they’d seemed on the first about 100 ladies that had been labored up after getting these uncommon outcomes on a take a look at that they thought was on their fetus, and nearly precisely half of them had most cancers.
Feltman: Mm.
Hercher: And it’s a must to take into account that this can be a group of younger people as a result of they’re all of childbearing age, proper?
Feltman: Proper.
Hercher: So to see such a powerful most cancers sign in that inhabitants, it actually blew me away. So I wished to know extra, and so I investigated into it.
Feltman: Yeah, completely. So backing up slightly bit, what’s the prenatal testing right here that we’re speaking about, and the way widespread is it? What number of pregnant persons are, are getting these exams?
Hercher: Hundreds of thousands, so it’s fairly widespread; a minimum of, I’d say, about 50 % of all pregnancies at present use this take a look at. It’s referred to as noninvasive prenatal testing—let’s simply name it NIPT.
So NIPT is a take a look at that got here alongside that type of solved an issue from the standpoint of anticipating {couples}. The issue was that earlier than NIPT, we provided testing for Down syndrome and different uncommon chromosomal displays within the fetus to basically each pregnant particular person, proper?
Feltman: Mm-hmm.
Hercher: However there have been type of two kinds of testing. And one was amniocentesis or CVS [chorionic villus sampling], the place you utilize a needle to get a pattern from both the placenta or the amniotic fluid within the uterus, and as that in all probability suggests to individuals, it’s invasive …
Feltman: Mm.
Hercher: Proper? And so, not everybody was comfy with that. And most significantly, though it was very small, there was a danger of shedding the being pregnant related to each of these exams. So there have been some—and costly, and it’s an enormous deal …
Feltman: Mm-hmm.
Hercher: And lots of people would fairly keep away from that needle if they may.
And there was one other kind of take a look at, which was merely a blood take a look at from [the] pregnant individual, that checked out biomarkers related to varied chromosomal points within the fetus. And that was a straightforward take a look at and low-cost however had tons of false positives.
Feltman: Mm.
Hercher: And actually, you understand, once I was first on this subject and would see prenatal sufferers, they’d are available in with a optimistic biomarker display screen, and you could possibly be fairly reassuring ’trigger, like, the possibilities had been normally—at all times better than not …
Feltman: Mm.
Hercher: That it was nothing, proper?
Feltman: Proper.
Hercher: In order that’s good, but in addition, it implies that lots of people get agitated, have follow-up care, and so forth, and prove that it’s nothing. It wasn’t tremendous common, you understand?
Feltman: Proper.
Hercher: There was a push to search for a take a look at that will discover fetal cells within the maternal bloodstream …
Feltman: Mm.
Hercher: So you could possibly instantly take a look at the fetal DNA, however you wouldn’t need to get into the uterus in any trend.
Feltman: Proper.
Hercher: Actually, that’s by no means turned out to be potential. It’s very difficult. It’s tough. There’s been type of tantalizing hints, however no, it’s by no means been profitable as a take a look at. However what a Hong Kong–based mostly researcher realized was that, you understand, as cells die—in regular course of cell demise, as cells flip over, they dump little bits of DNA into the bloodstream.
Feltman: Mm.
Hercher: That’s not whenever you’re pregnant—that’s for everyone on a regular basis.
Feltman: Proper.
Hercher: And this will get very quickly cleaned up, recycled. So—and that DNA isn’t good and neatly contained in chromosomes; it’s chopped up into little items like a jigsaw puzzle …
Feltman: Mm.
Hercher: Which—it’s good to carry on to that picture, proper? And you may sequence these little items after which hint them again to what chromosome they got here from through the use of the information we’ve got of the human genome prefer it was the image on the quilt of the field …
Feltman: Proper.
Hercher: Once you’re doing a jigsaw puzzle, proper? So you may hint it proper again and determine, “Oh, this little phase got here from chromosome one; this little phase got here from chromosome 10,” and so forth. And people items ought to present up within the bloodstream in direct proportion to the dimensions of the chromosome. So chromosome one is the largest chromosome, so it ought to have probably the most items, proper?
Feltman: Mm-hmm.
Hercher: Like, that’s simply math. Like, for those who get a superb pattern, that’s what the pattern ought to appear like, from the largest to the smallest chromosome.
So for those who’re pregnant, a portion of that cell-free DNA, these little items, comes from the placenta.
Feltman: Mm-hmm.
Hercher: So what [Hong Kong–based researcher Dennis] Lo discovered was that you simply didn’t must disentangle the fetal DNA from the maternal DNA, which is tremendous difficult, with a view to get a way of whether or not the numbers had been off since you may simply assume that the maternal snippets of DNA would signify typical chromosomes since you know that individual’s chromosomes.
Feltman: Mm-hmm.
Hercher: And so any deviation from the anticipated numbers needs to be coming from the fetus. So it’s tremendous exhausting math. Like, it’s—you actually need to be very exact. However the thought of it’s fairly simple, proper? And it principally works. However what it means is: there’s fewer—not zero, it’s nonetheless a display screen—however there’s fewer false positives.
It’s actually fast, the adoption of this take a look at—goes from zero to tens of millions very, very quick. After which immediately, hardly ever however repeatedly, we begin seeing this humorous factor. The humorous factor [is] outcomes the place you’re seeing a sign of additional lacking chromosomes—not one however a number of and also you take a look at this report, and it’s presupposed to be a report on …
Feltman: Mm-hmm.
Hercher: Fetal chromosomes, and also you’re like, “This fetus shouldn’t be alive.”
Feltman: Proper.
Hercher: “This isn’t appropriate with life.” And but you take a look at the ultrasound, and there you could have a fortunately growing fetus—appears high quality, appears regular. It’s what the docs name “discordant,” proper?
Feltman: Mm-hmm.
Hercher: It doesn’t make any sense. So we didn’t know—fairly know what to make of them, and the lab began off by simply type of saying, like, “We’re turning you these outcomes; we don’t perceive them.” They got here to name them “nonreportable” …
Feltman: Mm.
Hercher: Which is totally different from type of a “take a look at fail—let’s do it over.” These had been like, “Nope, don’t do it over. This simply doesn’t work. One thing’s off.”
Feltman: Proper.
Hercher: They usually didn’t know, however then they began to have, you understand, incidental findings the place the docs would come again and say, “Look, six months in the past I had this individual are available in, they usually had these nonreportable outcomes, and now I hear that this individual has most cancers.”
Feltman: Mm.
Hercher: And at first it was simply the occasional anecdote, which, you understand, you may’t actually ship a report based mostly on an occasional anecdote. So over time they began wanting into this; it turned clearer that what we had been getting was a sign, not from the fetus however from the mom. And it was occurring not usually however one in each 8,000 to 10,000 instances—which, when you could have tens of millions of exams a yr, is absolutely fairly numerous individuals.
Feltman: Yeah, it feels like, you understand, it was a protracted course of to type of flip the anecdata right into a sign that was price pursuing. How did the researchers answerable for this research get actually and determine what was happening?
Hercher: Effectively, Diana Bianchi, who’s the principal investigator, is any person who’s been working with this take a look at, NIPT, actually from its very starting. And I believe what Dr. Bianchi discovered was that there have been some research displaying a fairly intriguing sign of most cancers, however a few of them had been from the labs themselves. In the US you could have a number of labs—you could have, like, 12 totally different labs that supply NIPT. Each is barely totally different. They’re not precisely the identical. And so it was exhausting to get, like, one easy reply. And with no easy reply you may ship a report again saying, “We’re involved about maternal malignancy,” however is the insurance coverage firm gonna pay for that?
Feltman: Mm.
Hercher: It’s not validated. And likewise, like, had been the docs gonna take it significantly? They hadn’t seen it earlier than. Like, there was a whole lot of methods for this not for use correctly …
Feltman: Proper.
Hercher: This data to get misplaced.
So this group at [the National Institutes of Health] mentioned, like, “Proper, okay, we’re gonna do an goal research.” Anyone that matches these standards—discordant outcomes—that individual, they’d pay all of their bills to return to NIH, they’d give them a full and whole workup, and that will enable them to see what number of of them truly, if any, had most cancers; what was the efficient manner of discovering it; what kind of cancers had been these; so on—all these questions—and supply steerage for the labs.
They usually thought they had been gonna discover one thing, however what Dr. Bianchi mentioned to me—so I mentioned, “Have been you shocked by what number of?” She mentioned, “Hell yeah, we had been shocked.” I imply, nearly half. And for those who truly checked out it carefully it mentioned within the paper that they may additional refine the sign. So when the ladies confirmed up they usually truly had greater than two full chromosomes lacking or added, I believe the numbers had been 49 of them had this sample …
Feltman: Mm.
Hercher: And 47 of these individuals had most cancers.
Feltman: Wow.
Hercher: In order that was [a] actually, actually sturdy sign, however even within the greater group, you understand, they had been seeing. And there have been different issues: Generally individuals had fibroids. Generally the take a look at was incorrect, and, you understand. Generally there have been different issues. Generally there’s people who they suppose, like, “Effectively, we don’t know. We gotta comply with these individuals out. Perhaps we simply can’t discover it but,” you understand?
Feltman: Mm.
Hercher: However actually a whole lot of them already had most cancers, and basically they both had no signs or they’d signs that had been simply mistaken for being pregnant.
Feltman: Proper. One thing that basically struck me in your piece was—and I’m undoubtedly oversimplifying this—however you bought into type of the concept in medication persons are very uncomfortable in regards to the thought of pregnant individuals with most cancers and it’s a really fraught matter and the way possibly that contributed considerably to the disconnect between the various items right here as this knowledge was coming collectively. Might you discuss slightly bit extra about that?
Hercher: Certain, I believe there’s totally different items to it. One is solely, as Dr. Bianchi mentioned, there’s type of a whole lot of historical past across the thought of, like, “Don’t contact pregnant individuals,” you understand?
Feltman: Mm.
Hercher: It’s not comfy. And, you understand, medication’s fairly siloed, so the OB-GYN’s not tremendous comfy having sufferers who’ve most cancers or may need most cancers. How does he work that up? It actually requires them to exit and discover oncologists who they’d be capable to clarify this to, proper?
Feltman: Mm-hmm.
Hercher: As a result of this isn’t a way that some—you understand, present up they usually’re like, “Effectively, they haven’t any signs.”
Feltman: Proper.
Hercher: “There’s no explicit motive besides I’ve this funky take a look at consequence, and we don’t know what most cancers this could be.” I imply, it’s a really odd presentation …
Feltman: Certain.
Hercher: Proper? And the oncologists are clearly not used to working with pregnant individuals.
We talked to 1 one who had this expertise—I talked to 1 lady who confirmed up for her prenatal outcomes session, and the geneticist she was speaking to mentioned, “Effectively, truly, you understand, we predict this sign is coming from you.” And he or she nearly didn’t comply with up on it as a result of, she mentioned, “I felt nice.”
Feltman: Proper.
Hercher: “I truly, you understand, had by no means been in higher form in my life. I used to be like, ‘That’s loopy. I’m high quality. Like, I assumed you had been gonna say there’s one thing in regards to the fetus.’” And the individual type of mentioned, “Look, go get the workup.” So she did. And to her shock and horror they discovered a pretty big and aggressive lymphoma, and she or he needed to be handled throughout her being pregnant. She had her final chemotherapy remedy two weeks earlier than she gave delivery, and she or he mentioned that she was actually fortunate as a result of in Washington, [D.C.], she was capable of finding a, a middle the place they may do coordinated care. And for her that meant that, you understand, OB would ship any person over each time she had an infusion to only verify on the newborn’s heartbeat, be certain it was okay. You already know, there was fixed communication backwards and forwards. And clearly not all people’s going to have that out there, and it may be scary and uncomfortable.
Past that there’s an entire different layer of this story, which is that individuals who uncover their—have most cancers throughout a being pregnant, there are occasions when acceptable care means discussing terminating the being pregnant as a result of which will lead to a greater end result. That doesn’t imply that they need to do it or they’re—that’s the choice they’re gonna select, however within the state of affairs the place finest outcomes are related to remedy that may solely be undertaken if an individual isn’t pregnant …
Feltman: Mm-hmm.
Hercher: Then that’s a dialogue the oncologist must have. However that’s one of many areas the place we’ve seen, since 2022, that exceptions are actually difficult in stringent antiabortion legal guidelines.
Feltman: Proper.
Hercher: As a result of fairly often the physician is caught in a bind the place the usual of care can be to current that as one of many choices, however the regulation might say you’re not allowed to current that as an choice except the individual is actually dying, and, you understand, in oncology that’s not the best way that’s gonna look. What’s it gonna appear like is: What are your possibilities of being alive in 5 years? What are your possibilities of being alive to boost this little one?
And so the legal guidelines weren’t written by the docs, they don’t actually have a whole lot of flexibility or nuance in them, and in these instances oncologists may be actually in a bind. And so this take a look at, which doesn’t establish, you understand—there’s no more individuals getting most cancers due to the take a look at, however what it’s actually doing is: the early identification is shifting individuals that will possibly be recognized with most cancers a month, two months, six months, two years later, that’s occurring earlier on and whereas they’re pregnant.
Feltman: Proper.
Hercher: So it simply creates extra of those type of tough and conflictual conditions.
Feltman: Yeah, properly, and, you understand, with the common age of being pregnant being increased and, after all, seeing these upticks in most cancers in, in youthful cohorts, you understand, is there concern that this is a matter we have to get higher at dealing with in, normally? The concept of individuals having cancers recognized throughout being pregnant?
Hercher: Yeah, no, completely. I imply, all around the world, the common age at which individuals have youngsters is rising, and, you understand, most cancers’s a—direct, in a linear trend, related to older age. So we do have extra—our numbers of what share of girls who’re pregnant will current with most cancers are out-of-date. So it’s undoubtedly a uncommon factor, but it surely’s an rising uncommon factor.
And the opposite factor, which Dr. Bianchi actually pressured, is: we’re additionally getting higher at having the ability to deal with individuals whereas they’re pregnant.
Feltman: Mm.
Hercher: We are able to do extra of it than we thought. She advised me—I assumed this was actually hanging—she advised me that, significantly, there was a bunch in Belgium that’s been very lively about taking a look at this and, like, being inventive in regards to the methods to deal with, and one of many issues they’ve is the dye that you simply use whenever you do that take a look at to search for tumors, the distinction dye, was poisonous for people who find themselves pregnant, they usually discovered that by getting them to drink an entire lot of pineapple juice, that labored as properly …
Feltman: Wow, yeah.
Hercher: So, you understand, they’re discovering that issues that possibly they thought they couldn’t do, they actually can do, and it actually, actually emphasizes the necessity to not lose these individuals …
Feltman: Mm.
Hercher: To ensure that they’re discovered when they are often discovered. I imply, a quantity that basically caught with me from this: of these 47 people with most cancers, by the point they went to press with this text, six of these—bear in mind, comparatively younger—individuals had been useless.
Feltman: Wow.
Hercher: Yeah, so these weren’t a collection of trivial or meaningless findings. The commonest discovering was lymphoma. The second-most widespread discovering was [colorectal] most cancers, which, individually however relatedly, is on the rise in youthful adults in America at present.
So there are a whole lot of traits type of, like, weaving their manner out and in of this story. It was one of many ones that I discovered it so fascinating to write down about. It’s an vital discovering by itself, but it surely’s additionally one thing it’s a must to situate inside the context of what’s occurring in the US, proper? And it, it asks us to, you understand, work exterior of silos and be actually sensible and actually, you understand intervene, and it’s one more factor the place I’m apprehensive in regards to the fractures in our well being care. ’Trigger proper now they’d a solution, they’ve assets for individuals on this place …
Feltman: Mm.
Hercher: They’re like, “You must go to the IDENTIFY research.” They may fly you to NIH, cowl your entire prices. However when the research goes away what number of of those persons are gonna have to actually combat with their insurance coverage corporations …
Feltman: Yeah.
Hercher: To get this coated? And if not, is it simply gonna be, you understand, like, in case you have cash to pay for it out of pocket, are you going to have the ability to get this care however in any other case not, you understand?
So I actually wanna shine some mild on this. I hope that folks see the significance of, A, responding to those findings with an acceptable workup and, B, that they need to be coated.
Feltman: Yeah, completely.
Thanks a lot for taking the time to return on and, and inform us slightly bit about your article. I undoubtedly encourage our, our listeners to test it out in full on SciAm.com.
Hercher: Thanks, it was a pleasure to be right here.
Feltman: That’s all for at present’s episode. We’ll be again with our typical information roundup on Monday.
Science Rapidly is produced by me, Rachel Feltman, together with Fonda Mwangi, Kelso Harper, Naeem Amarsy and Jeff DelViscio. This episode was edited by Alex Sugiura. Shayna Posses and Aaron Shattuck fact-check our present. Our theme music was composed by Dominic Smith. Subscribe to Scientific American for extra up-to-date and in-depth science information.
For Scientific American, that is Rachel Feltman. Have a fantastic weekend!
